Bruckel Jeffrey T, Wong Sandra L, Chan Paul S, Bradley Steven M, Nallamothu Brahmajee K
University of Rochester Medical Center, Rochester, NY; Dartmouth-Hitchcock Medical Center; The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH; St Luke's Mid-America Heart Institute; University of Missouri-Kansas City, Kansas City, MO; Minneapolis Heart Institute, Minneapolis, MN; University of Michigan Health System; Michigan Integrated Center for Health Analytics and Medical Prediction; and Ann Arbor VA Center for Clinical Management and Research, Ann Arbor, MI.
J Oncol Pract. 2017 Oct;13(10):e821-e830. doi: 10.1200/JOP.2016.020404. Epub 2017 Aug 1.
Little is known regarding patterns of resuscitation care in patients with advanced cancer who suffer in-hospital cardiac arrest (IHCA).
In the Get With The Guidelines - Resuscitation registry, 47,157 adults with IHCA with and without advanced cancer (defined as the presence of metastatic or hematologic malignancy) were identified at 369 hospitals from April 2006 through June 2010. We compared rates of return of spontaneous circulation (ROSC) and survival to discharge between groups using multivariable models. We also compared duration of resuscitation effort and resuscitation quality measures.
Overall, 6,585 patients with IHCA (14.0%) had advanced cancer. Patients with advanced cancer had lower multivariable-adjusted rates of ROSC (52.3% [95% CI, 49.5% to 55.3%] v 56.6% [95% CI, 53.8% to 59.5%]; P < .001) and survival to discharge (7.4% [95% CI, 6.6% to 8.4%] v 13.4% [95% CI, 12.1% to 14.8%]; P < .001). Among nonsurvivors who died during resuscitation, patients with advanced cancer had better performance on most resuscitation quality measures. Among patients with ROSC, patients with advanced cancer were made Do Not Attempt Resuscitation (DNAR) more frequently within 48 hours (adjusted relative risk, 1.30 [95% CI, 1.24 to 1.37]; P < .001). Adjustment for DNAR status explained some of the immediate effect of advanced cancer on survival; however, survival remained significantly lower in patients with cancer.
Patients with advanced cancer can expect lower survival rates after IHCA compared with those without advanced cancer, and they are more frequently made DNAR within 48 hours of ROSC. These findings have important implications for discussions of resuscitation care wishes with patients and can better inform end-of-life discussions.
对于晚期癌症患者发生院内心脏骤停(IHCA)后的复苏护理模式,我们了解甚少。
在“遵循指南 - 复苏”注册研究中,于2006年4月至2010年6月期间,在369家医院识别出47157例发生IHCA的成年患者,其中有或没有晚期癌症(定义为存在转移性或血液系统恶性肿瘤)。我们使用多变量模型比较了两组之间的自主循环恢复(ROSC)率和出院生存率。我们还比较了复苏努力的持续时间和复苏质量指标。
总体而言,6585例发生IHCA的患者(14.0%)患有晚期癌症。晚期癌症患者经多变量调整后的ROSC率较低(52.3% [95% CI,49.5%至55.3%]对56.6% [95% CI,53.8%至59.5%];P <.001),出院生存率也较低(7.4% [95% CI,6.6%至8.4%]对13.4% [95% CI,12.1%至14.8%];P <.001)。在复苏期间死亡的非幸存者中,晚期癌症患者在大多数复苏质量指标上表现更好。在恢复自主循环的患者中,晚期癌症患者在48小时内更频繁地被下达不要尝试复苏(DNAR)医嘱(调整后的相对风险,1.30 [95% CI,1.24至1.37];P <.001)。对DNAR状态进行调整解释了晚期癌症对生存的一些直接影响;然而,癌症患者的生存率仍然显著较低。
与没有晚期癌症的患者相比,晚期癌症患者发生IHCA后的生存率较低,并且在恢复自主循环后48小时内更频繁地被下达DNAR医嘱。这些发现对于与患者讨论复苏护理意愿具有重要意义,并能更好地为临终讨论提供信息。